1L-myo-inositol (inositol) is vital for the biogenesis of mycothiol, phosphatidylinositol and glycosylphosphatidylinositol anchors linked to complex carbohydrates in Mycobacterium tuberculosis. All these cellular components are thought to play important roles in host-pathogen interactions and in the survival of the pathogen within the host. However, the inositol biosynthetic pathway in M. tuberculosis is not known. To delineate the pathways for inositol formation, we employed a unique combination of tertiary structure prediction and yeast-based functional assays. Here, we describe the identi®cation of the gene for mycobacterial INO1 that encodes inositol-1-phosphate synthase distinct in many respects from the eukaryotic analogues.
Inositol is an essential metabolite in all eukaryotic cells, but is found rarely in prokaryotes. Those prokaryotic species in which inositol has been found to occur include Streptomyces, ice nucleating bacteria, and mycobacteria (Pittner et al., 1979; Kozlof et al., 1991; Bornemann et al., 1997; Parish et al., 1997) . The mycobacterial cellular envelope contains a high proportion of phosphatidylinositol (PI), phosphatidylinositol mannoside (PIM), and glycosylphosphatidylinositol (GPI) anchor linked to arabinomannan (LAM) and mannan (LM) (Chatterjee et al., 1992; Hunter et al., 1990) . These cellular components, LAM in particular, are thought to play crucial roles in the host-pathogen interaction and are particularly important for the survival of the pathogen in the hostile environment within the host (Sibley et al., 1988; Chan et al., 1991; Schlesinger et al., 1994) . LAM has also been known to participate in the receptor-mediated phagocytosis of Mycobacterium tuberculosis, in addition to modulating the host immune response (Besra et al., 1997) . The non-reducing termini of a variety of LAMs from rapidly growing strains of mycobacteria have been demonstrated to contain inositol phosphate capping (Khoo et al., 1995) . Moreover in Mycobacterium sp., inositol is a precursor of another important cellular metabolite, mycothiol. Mycothiol is a thiol required for maintaining the intracellular reducing environment (Bornemann et al., 1997; Newton et al., 1996) . Despite the important role played by inositol, the pathway for its biosynthesis has not yet been characterized in M. tuberculosis (Salman et al., 1999) .
Studies with eukaryotic systems have revealed that the sole pathway for inositol biosynthesis involves two steps. In the ®rst step, glucose-6-phosphate to inositol-1-phosphate conversion takes place through a complex reaction mediated by a single enzyme, inositol-1-phosphate synthase (EC 5.5.1.4). In the second step, inositol-1-phosphate is dephosphorylated by inositol-1-phosphatase (EC 3.1.3.25) (Chen & Charalompaus, 1964 , 1965 Majumdar et al., 1997) . The free inositol thus synthesized is subsequently used by the host as a precursor for generating inositol derived metabolities.
The ®rst enzyme in the biosynthesis of inositol, inositol-1-phosphate synthase, has been shown to be essential for the growth of yeast and fungi. Disrupting the INO1 gene in Saccharomyces cerevisiae, therefore, leads to cell death unless it is supplemented with exogenous inositol (Culbertson & Henry, 1975) . As Mycobacterium is an inositol prototroph, it is likely to be capable of synthesizing inositol de novo. In this study we have sought to examine the presence of inositol-1-phosphate synthase in M. tuberculosis, and to determine if the pathway of inositol biosynthesis is common in eukaryotes and prokaryotes.
Publicly available Mycobacterial genome database was searched with the BLAST program (Altschul et al., 1997) using the S. cerevisiae inositol-1-phosphate synthase (INO1p) amino acid sequence. The search revealed a very low degree of sequence homology to the Rv0046c open reading frame (ORF) of the M. tuberculosis H37Rv genome coding for a 367 amino acid residue-long protein (Cole et al., 1998) . The homology was suf®ciently low to escape it being identi®ed as the putative Mycobacterial inositol-1-phosphate synthase by standard computational methods. The percentage identity between S. cerevisiae INO1p and the protein product of Rv0046c was less than 15 %. Moreover, the sulfhydryl groups known to be important for the enzymatic activity of eukaryotic INO1p (Gumber et al., 1984) were not conserved in Rv0046c, giving rise to the speculation that Rv0046c may not possess the same activity. Thus, the assignment of the inositol-1-phosphate synthase function to the protein product of Rv0046c would not have been possible with the sequence data alone.
Inositol-1-phosphate synthase is known to utilize NAD as the cofactor (Majumdar et al., 1997) . We therefore searched for a putative NAD binding sequence in the Rv0046c protein. However, neither the presence of the signature GXGXXG motif (Wierenga et al., 1986) nor an exhaustive search through the PROSITE database (Hofmann et al., 1999) revealed any nucleotide binding motifs in the Rv0046c sequence. On the other hand, a tertiary structure prediction by threading the sequence onto known protein folds (Fischer et al., 1996) revealed a Rossmann fold in the N-terminal half of the Rv0046c protein sequence. The mycobacterial INO1p exhibited striking similarity to diamino pimelate (DAP) dehydrogenase NADP binding domain (Scapin et al., 1996) with a Z-score of 7.99. This score is signi®cantly higher than the con®-dence threshold limit set by the method, i.e. 4.8(AE1). Interestingly, two arginine residues involved in 2 H -phosphate binding in DAP dehydrogenase (Figure 1 ) are replaced by alanine residues in Rv0046c protein, thereby suggesting that Rv0046c may bind to NAD instead of NADP. Moreover, the sequence region predicted to be involved in nucleotide binding appeared to be highly conserved among the homologous prokaryotic and eukaryotic sequences (Figure 2) . The threading therefore suggested that the N-terminal domain of Rv0046c might be functionally important for nucleotide binding.
In order to examine if the 367 amino acid residue-long ORF might be coding for an INO1 enzyme, primers were designed to amplify the Rv0046c coding gene by using a standard polymerase chain reaction (PCR) protocol. M. tuberculosis H37Rv chromosomal DNA was used as the template. The PCR product so obtained was veri®ed by DNA sequencing. The PCR ampli®ed gene product was subsequently cloned downstream of a strong, constitutively expressed yeast glyceraldehyde-3-phosphate dehydrogenase (GPD) promoter of an yeast multicopy expression vector p426GPD (Mumberg et al., 1995; Sambrook et al., 1989) and the resulting plasmid was designated pBM002.
A yeast-based functional assay system was employed to determine if the ORF of Rv0046c indeed encoded an inositol-1-phosphate synthase enzyme. The assay was explored through functionally complementing the gene for yeast INO1 deletion mutation in S. cerevisiae, FY250 (MATa trp1 his3 ura3 leu2 Áinol::HIS3). This yeast strain is auxotrophic for inositol due to the disrupted INO1. The strain FY250 was transformed with plasmid pBM002 harboring mycobacterial putative INO1 gene and with the vector p426GPD as a control using standard protocols (Ito et al., 1983) . Transformants bearing pBM002 construct allowed growth on medium lacking inositol (Figure 3) , thereby suggesting that Rv0046c is capable of functionally complementing the yeast ino1 mutation. Further examination was carried out in liquid medium to ascertain the growth characteristics of the transformants harboring pBM002. The growth rate was examined in two separate de®ned media, one containing inositol but lacking uracil, and the other lacking both uracil and inositol. The strain FY250 containing the vector p426GPD was used as a control in both the media. As anticipated, the control transformants did not grow in the medium without inositol. However, they grew normally in a synthetic de®ned medium supplemented with 10 mM inositol with a doubling time of approximately 4.5 hours. The same host FY250 harboring the recombinant plasmid pBM002, on the Mycobacterial Inositol-1-phosphate Synthase other hand, exhibited normal growth pattern in the medium lacking exogenously added inositol. It had a doubling time of 4.5 hours, similar to the p426GPD containing transformant grown in inositol-containing medium. Thus, the growth characteristics strongly suggested that Rv0046c encodes inositol-1-phosphate synthase activity.
In order to con®rm further that pBM002 harbors the functionally active mycobacterial inositol-1-phosphate synthase, inositol excretion was detected by following the procedure by Greenberg et al., 1982) . To detect inositol excretion, randomly picked yeast transformants were spotted on agar plates lacking inositol. A lawn of the yeast indicator strain BRS1005 (MATa/MATa, ade1/ade1, ino1-13/ino1-13) was spread on the same plate prior to spotting the transformants. Inositol auxotrophic yeast strain FY250 containing pBM002 could be distinctly seen with red halo surrounding them. The halo is generated by the excreted inositol which permits the growth of the red indicator strain (BRS1005), which is also an inositol auxotroph (data not shown). Thus, FY250 transformed with pBM002 is clearly capable of synthesizing inositol and excreting it into the medium.
The functional identi®cation of Rv0046c reveals a novel class of prokaryotic inositol-1-phosphate synthase. The 367 residue-long enzyme is considerably shorter than the eukaryotic analogues which are at least 500 to 550 residues long. The Rossmann fold domain successfully identi®ed, not by conventional approaches but exclusively through sequence threading of known protein folds, indicated that it may be involved in nucleotide binding. The absence of conserved catalytic sulfhydryl groups, as has been shown to be critical in the plant and other eukaryotic enzymes, was the most signi®cant factor for the inability of standard computational procedures to unambiguously establish the mycobacterial INO1 function (Gumber et al., 1984; Majumdar et al., 1997) . Although the critical sufhydryl group does not appear to be conserved in the Rv0046c sequence, the presence of a Cys residue, Cys26 (equivalent to Leu14 in the DAP Growth pattern of the inositol-requiring S. cerevisiae strain FY250 transformed with (a) p426GPD as control and (b) Mtb INO1 in pBM002. All the constructs were selected ®rst in a synthetic medium containing inositol (inositol) but lacking uracil (Àura), while the cloned gene was subsequently selected in the medium lacking inositol (Àinositol). Thus, the transformants were grown on de®ned synthetic medium (Bachhawat et al., 1995) containing plus inositol minus uracil (inositol, Àura), minus inositol minus uracil (Àinositol, Àura), and minus inositol plus uracil (Àinositol, ura). The concentration of inositol was 10 mM. structure as shown in Figure 1 ) next to the predicted nucleotide binding site suggests that Cys26 may take part in the proposed oxidation-reduction reaction. Interestingly, Cys26 appears to be conserved in all other prokaryotic homologous sequences (Figure 2) . Also, the DAP dehydrogenase structure shows the presence of an important Cys65 residue very close to Leu14 (Scapin et al., 1996) , reinforcing our prediction that Cys26 may act as the catalytic redox center. This prediction can be further tested by site-directed mutagenesis.
In conclusion, we have cloned the inositol-1-phosphate synthase from M. tuberculosis H37Rv and demonstrated that it can functionally compensate for the yeast INO1 mutation. The INO1 of Mycobacterium and other homologous prokaryotic genes revealed a distinct class of this enzyme. Although our demonstration that Rv0046c encodes an INO1 activity, this does not rule out the possibility that another polypeptide in M. tuberculosis may play a similar role. Generating an INO1 knock-out would conclusively demonstrate the same. Considering the important role of inositol in a variety of metabolic pathways in M. tuberculosis and the difference in the prokaryotic and eukaryotic enzymes, we suggest that the enzyme could be a potentially attractive drug target.
